Buzzworthy developments of the past few days.

About 40% of rads said they accept studies across all areas of expertise. Yet, less than half are “very confident” reading them. 

Gradient Health's database now spans 10 countries, 1,000 hospitals, and more than 350 million patient studies.

ACR recently highlighted the collaboration, labeling scope of practice as “one of the leading issues that are addressed by state legislatures.” 

America’s two major political parties are talking in practical unison about working things out over a common cause.

Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.

Anumana, Pfizer and Mayo Clinic all worked together to develop the advanced algorithm. The groups are now targeting full regulatory approval in the U.S., Europe and Japan.

Artificial intelligence will be one of the hottest topics at the upcoming American Society of Echocardiography meeting in National Harbor, Maryland. 

While radiologists and current trainees are either prepared to or are already embracing artificial intelligence, a significant portion of medical students shy away from radiology because of AI.

Did your facility make the cut? For its 2023-2024 list, U.S. News and World Report evaluated data from 119 hospitals and surveyed thousands of pediatric specialists.